IDEX Reports Second Quarter EPS of 88 Cents and Raises Full Year EPS Guidance to $3.50 – $3.55
Second Quarter 2014 Highlights
- Orders increased 9 percent, 7 percent organically
- Sales increased 5 percent, 4 percent organically
- Operating margin of 20.5 percent was up 130 basis points from the prior year
-
EPS of
88 cents was 16 percent higher than prior year EPS of76 cents - Acquired Aegis Flow Technologies
Second Quarter 2014
Orders in the quarter of
Second quarter 2014 gross margin of 44.1 percent was up 110 basis points
from the prior year period, while operating income of
Second quarter net income was
The Company completed the repurchase of 602 thousand shares of common
stock for
“IDEX completed the first half of 2014 with another solid quarter and good momentum for the second half of the year. We have a clear focus to invest in organic growth, while achieving productivity gains. These investments require a greater use of free cash flow, but provide a base for long-term organic growth. The focus on various organic initiatives and core product line strategies is yielding benefits and, as a result, organic revenue growth has accelerated to 6 percent in the first-half of 2014.
We are focused on total shareholder return by increasing organic growth
and maintaining a disciplined approach to acquisitions, shareholder
dividends and share repurchases. In April, we successfully completed the
acquisition of Aegis Flow Technologies (“Aegis”), a leader in specialty
chemical processing valves. Aegis will operate in our Chemical, Food &
Process platform and expand our presence in the region around the Gulf
of
Geographically, we see stability in
Chairman and Chief Executive Officer
Second Quarter 2014 Business Highlights
Fluid & Metering Technologies
-
Sales in the second quarter of
$226 million reflected a slight increase compared to the second quarter of 2013 (-2 percent organic, +1 percent acquisition and +1 percent foreign currency translation). - Operating margin of 24.6 percent represented a 30 basis point decrease compared with the second quarter of 2013 primarily due to acquisition related charges.
Health & Science Technologies
-
Sales in the second quarter of
$186 million reflected a 3 percent increase compared to the second quarter of 2013 (+1 percent organic and +2 percent foreign currency translation). - Operating margin of 19.5 percent represented a 40 basis point increase compared with the second quarter of 2013 primarily due to higher volume and productivity initiatives.
Fire & Safety/Diversified Products
-
Sales in the second quarter of
$136 million reflected a 19 percent increase compared to the second quarter of 2013 (+17 percent organic and +2 percent foreign currency translation). - Operating margin of 26.4 percent represented a 570 basis point increase compared with the second quarter of 2013 primarily due to volume leverage and productivity initiatives as well as a prior year charge associated with a facility disposal in 2013.
For the second quarter of 2014, Fluid & Metering Technologies contributed 41 percent of sales and 44 percent of operating income; Health & Science Technologies accounted for 34 percent of sales and 28 percent of operating income; and Fire & Safety/Diversified Products represented 25 percent of sales and 28 percent of operating income.
EBITDA and Free Cash Flow
EBITDA means earnings before interest, income taxes, depreciation and amortization, while free cash flow means cash flow from operating activities less capital expenditures plus the excess tax benefit from stock-based compensation. Management uses these non-GAAP financial measures as internal operating metrics and for enterprise valuation purposes. Management believes these measures are useful as analytical indicators of leverage capacity and debt servicing ability, and uses them to measure financial performance as well as for planning purposes. However, they should not be considered as alternatives to net income, cash flow from operating activities or any other items calculated in accordance with U.S. GAAP, or as an indicator of operating performance. The definitions of EBITDA and free cash flow used here may differ from those used by other companies.
EBITDA and
For the Quarter Ended | ||||||||||||||||||
June 30, | March 31, | |||||||||||||||||
2014 | 2013 | Change | 2014 | Change | ||||||||||||||
Income before Taxes | $ | 101.5 | $ | 88.4 | 15 | % | $ | 104.2 | (3 | %) | ||||||||
Depreciation and Amortization | 19.4 | 20.1 | (3 | %) | 19.3 | 1 | % | |||||||||||
Interest Expense | 10.4 | 10.6 | (2 | %) | 10.5 | (1 | %) | |||||||||||
EBITDA | $ | 131.3 | $ | 119.1 | 10 | % | $ | 134.0 | (2 | %) | ||||||||
Cash Flow from Operating Activities | $ | 92.0 | $ | 109.3 | (16 | %) | $ | 74.2 | 24 | % | ||||||||
Capital Expenditures | (12.5 | ) | (8.2 | ) | 52 | % | (10.8 | ) | 16 | % | ||||||||
Excess Tax Benefit from Stock-Based Compensation | 0.8 | 2.3 | (65 | %) | 2.9 | (72 | %) | |||||||||||
Free Cash Flow | $ | 80.3 | $ | 103.4 | (22 | %) | $ | 66.3 | 21 | % | ||||||||
Conference Call to be Broadcast over the Internet
IDEX will broadcast its second quarter earnings conference call over the
Internet on
Forward-Looking Statements
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act of 1934, as amended. These statements may relate to, among other things, capital expenditures, cost reductions, cash flow, and operating improvements and are indicated by words or phrases such as “anticipate,” “estimate,” “plans,” “expects,” “projects,” “should,” “will,” “management believes,” “the company believes,” “the company intends,” and similar words or phrases. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this news release. The risks and uncertainties include, but are not limited to, the following: economic and political consequences resulting from terrorist attacks and wars; levels of industrial activity and economic conditions in the U.S. and other countries around the world; pricing pressures and other competitive factors, and levels of capital spending in certain industries – all of which could have a material impact on order rates and IDEX’s results, particularly in light of the low levels of order backlogs it typically maintains; its ability to make acquisitions and to integrate and operate acquired businesses on a profitable basis; the relationship of the U.S. dollar to other currencies and its impact on pricing and cost competitiveness; political and economic conditions in foreign countries in which the company operates; interest rates; capacity utilization and the effect this has on costs; labor markets; market conditions and material costs; and developments with respect to contingencies, such as litigation and environmental matters. The forward-looking statements included here are only made as of the date of this news release, and management undertakes no obligation to publicly update them to reflect subsequent events or circumstances. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented here.
About IDEX
For further information on
(Tables follow)
IDEX CORPORATION | ||||||||||||||
Condensed Statements of Consolidated Operations | ||||||||||||||
(in thousands except per share amounts) | ||||||||||||||
(unaudited) | ||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||
June 30, | June 30, | |||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||
Net sales | $ | 546,693 | $ | 518,445 | $ | 1,090,689 | $ | 1,012,893 | ||||||
Cost of sales | 305,561 | 295,596 | 605,137 | 578,047 | ||||||||||
Gross profit | 241,132 | 222,849 | 485,552 | 434,846 | ||||||||||
Selling, general and administrative expenses | 129,044 | 123,290 | 259,629 | 240,575 | ||||||||||
Operating income | 112,088 | 99,559 | 225,923 | 194,271 | ||||||||||
Other (income) expense - net | 137 | 573 | (707 | ) | (706 | ) | ||||||||
Interest expense | 10,405 | 10,597 | 20,862 | 21,154 | ||||||||||
Income before income taxes | 101,546 | 88,389 | 205,768 | 173,823 | ||||||||||
Provision for income taxes | 29,769 | 25,828 | 59,443 | 49,962 | ||||||||||
Net income | $ | 71,777 | $ | 62,561 | $ | 146,325 | $ | 123,861 | ||||||
Earnings per Common Share: | ||||||||||||||
Basic earnings per common share (a) | $ | 0.89 | $ | 0.76 | $ | 1.81 | $ | 1.50 | ||||||
Diluted earnings per common share (a) | $ | 0.88 | $ | 0.76 | $ | 1.79 | $ | 1.49 | ||||||
Share Data: | ||||||||||||||
Basic weighted average common shares outstanding | 80,106 | 81,829 | 80,317 | 82,013 | ||||||||||
Diluted weighted average common shares outstanding | 81,149 | 82,734 | 81,362 | 82,943 | ||||||||||
Condensed Consolidated Balance Sheets | ||||||||||||||
(in thousands) | ||||||||||||||
(unaudited) | ||||||||||||||
June 30, | December 31, | |||||||||||||
2014 | 2013 | |||||||||||||
Assets | ||||||||||||||
Current assets | ||||||||||||||
Cash and cash equivalents | $ | 485,335 | $ | 439,629 | ||||||||||
Receivables - net | 272,151 | 253,226 | ||||||||||||
Inventories | 254,182 | 230,967 | ||||||||||||
Other current assets | 69,858 | 67,131 | ||||||||||||
Total current assets | 1,081,526 | 990,953 | ||||||||||||
Property, plant and equipment - net | 223,395 | 213,488 | ||||||||||||
Goodwill and intangible assets | 1,664,028 | 1,660,683 | ||||||||||||
Other noncurrent assets | 22,048 | 22,453 | ||||||||||||
Total assets | $ | 2,990,997 | $ | 2,887,577 | ||||||||||
Liabilities and shareholders' equity | ||||||||||||||
Current liabilities | ||||||||||||||
Trade accounts payable | $ | 146,827 | $ | 133,312 | ||||||||||
Accrued expenses | 142,493 | 150,751 | ||||||||||||
Short-term borrowings | 111,539 | 1,871 | ||||||||||||
Dividends payable | 22,516 | 18,675 | ||||||||||||
Total current liabilities | 423,375 | 304,609 | ||||||||||||
Long-term borrowings | 705,326 | 772,005 | ||||||||||||
Other noncurrent liabilities | 237,409 | 237,974 | ||||||||||||
Total liabilities | 1,366,110 | 1,314,588 | ||||||||||||
Shareholders' equity | 1,624,887 | 1,572,989 | ||||||||||||
Total liabilities and shareholders' equity | $ | 2,990,997 | $ | 2,887,577 |
IDEX CORPORATION | |||||||||||||||||
Company and Business Group Financial Information | |||||||||||||||||
(dollars in thousands) | |||||||||||||||||
(unaudited) | |||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||
June 30, (b) | June 30, (b) | ||||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||
Fluid & Metering Technologies | |||||||||||||||||
Net sales | $ | 226,100 | $ | 225,488 | $ | 449,461 | $ | 437,243 | |||||||||
Operating income (c) | 55,623 | 56,115 | 112,030 | 104,194 | |||||||||||||
Operating margin | 24.6 | % | 24.9 | % | 24.9 | % | 23.8 | % | |||||||||
Depreciation and amortization | $ | 6,746 | $ | 7,012 | $ | 13,298 | $ | 13,972 | |||||||||
Capital expenditures | 3,554 | 2,507 | 7,563 | 5,283 | |||||||||||||
Health & Science Technologies | |||||||||||||||||
Net sales | $ | 185,672 | $ | 180,867 | $ | 372,047 | $ | 353,735 | |||||||||
Operating income (c) | 36,137 | 34,522 | 72,366 | 66,789 | |||||||||||||
Operating margin | 19.5 | % | 19.1 | % | 19.5 | % | 18.9 | % | |||||||||
Depreciation and amortization | $ | 10,690 | $ | 10,947 | $ | 21,399 | $ | 21,739 | |||||||||
Capital expenditures | 5,318 | 4,168 | 8,827 | 6,954 | |||||||||||||
Fire & Safety/Diversified Products | |||||||||||||||||
Net sales | $ | 136,182 | $ | 114,236 | $ | 273,466 | $ | 225,749 | |||||||||
Operating income (c) | 35,985 | 23,676 | 75,633 | 51,908 | |||||||||||||
Operating margin | 26.4 | % | 20.7 | % | 27.7 | % | 23.0 | % | |||||||||
Depreciation and amortization | $ | 1,672 | $ | 1,741 | $ | 3,352 | $ | 3,449 | |||||||||
Capital expenditures | 2,692 | 741 | 4,499 | 2,221 | |||||||||||||
Company | |||||||||||||||||
Net sales | $ | 546,693 | $ | 518,445 | $ | 1,090,689 | $ | 1,012,893 | |||||||||
Operating income | 112,088 | 99,559 | 225,923 | 194,271 | |||||||||||||
Operating margin | 20.5 | % | 19.2 | % | 20.7 | % | 19.2 | % | |||||||||
Depreciation and amortization (d) | $ | 19,416 | $ | 20,077 | $ | 38,673 | $ | 39,916 | |||||||||
Capital expenditures | 12,490 | 8,197 | 23,299 | 15,822 | |||||||||||||
(a) | Calculated by applying the two-class method of allocating earnings to common stock and participating securities as required by ASC 260, Earnings Per Share. | ||||||||||||||||
(b) | Three and six month data includes acquisitions of Aegis (April 2014) in the Fluid & Metering Technologies segment and FTL (March 2013) in the Health & Science Technologies segment from the date of acquisition. | ||||||||||||||||
(c) | Segment operating income excludes unallocated corporate operating expenses. | ||||||||||||||||
(d) | Depreciation and amortization excludes amortization of debt issuance expenses. |
Source:
IDEX Corporation
Investor Contact:
Heath Mitts
Senior
Vice President and Chief Financial Officer
(847) 498-7070